Cobalt Strikes Back At Pfizer In Lyrica Patent Spat
Cobalt Laboratories Inc. has hit back in Pfizer Inc.'s infringement suit over patents related to the nerve pain medication Lyrica, filing counterclaims seeking declaratory judgments of noninfringement and invalidity....To view the full article, register now.
Already a subscriber? Click here to view full article